Wey L Leong

Wey L Leong

UNVERIFIED PROFILE

Are you Wey L Leong?   Register this Author

Register author
Wey L Leong

Wey L Leong

Publications by authors named "Wey L Leong"

Are you Wey L Leong?   Register this Author

16Publications

362Reads

26Profile Views

Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.

Clin Cancer Res 2018 11 31;24(22):5685-5696. Epub 2018 Jul 31.

The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0554DOI Listing
November 2018

B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.

Cancer Immunol Res 2015 Feb 19;3(2):184-95. Epub 2014 Dec 19.

Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0113DOI Listing
February 2015

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

BMC Cancer 2011 Jun 16;11:253:1-13. Epub 2011 Jun 16.

Ontario Cancer Institute and Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128009PMC
June 2011

Feasibility study of autofluorescence mammary ductoscopy.

J Biomed Opt 2009 Jul-Aug;14(4):044036

Ontario Cancer Institute, University Health Network, 7-417 610 University Avenue, Toronto, M5G 2M9 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.3210773DOI Listing
December 2009

Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed.

Ann Surg Oncol 2008 Jun 7;15(6):1710-6. Epub 2008 Mar 7.

Department of Surgical Oncology, Princess Margaret Hospital, University Health Network and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-9858-5DOI Listing
June 2008

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.

Ann Surg Oncol 2007 Feb 14;14(2):638-45. Epub 2006 Nov 14.

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-006-9211-9DOI Listing
February 2007

Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature.

J Surg Oncol 2004 Sep;87(3):143-5

General Surgery and Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.20103DOI Listing
September 2004

Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity.

J Surg Oncol 2003 Mar;82(3):143-6

Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.10205DOI Listing
March 2003

Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.

J Surg Oncol 2002 Mar;79(3):180-7

Division of Surgical Oncology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.10062DOI Listing
March 2002